A banner featuring a sample box and dried vegetables
Home
Videos
The Launch of an Awa...

The Launch of an Award Winning Production Process for Mycoprotein

13 Jan 2017 | 3FBio

3f Bio, a technology spin-out company from the University of Strathclyde (UoS) scooped first prize in the Start-Up Innovation Challenge for its vision to address global needs for sustainable proteins. 3f Bio is developing patented zero-waste technology for the large scale integrated production of food (mycoprotein), fuel (bioethanol) and feed (DDGS animal feed). 3f Bio CEO, Jim Laird said: “3f Bio is developing novel technology which halves the cost of mycoprotein, the main ingredient in the brand Quorn,” he said. “We have demonstrated proof of concept at lab scale and our next phase working with a technology partner next year. We forecast the first mycoprotein product using our technology being on sale in 2020,” he told FoodIngredientsFirst in an interview after winning the award.

This Rob Wires at the HIE in Frankfurt.

I'm here with Jim Laird, who is the CEO of 3 FBO, and the company just won the Startup Innovation Challenge Award here at at HIE.

Congratulations, Jim.

What, what is the product that you offer?

Yeah, delighted to be at HIE.

Our product is an integrated zero waste process.

We produce microprotein, and microprotein is a very high quality protein, solely commercialized under the brand corn just now, but our process is looking to half the cost.

And make it a genuine protein for global proteins solution for growing populations.

Can you explain the process very briefly to me?

The process combines two very established established processes.

It first takes the bio refinery process to make bioethanol, which uses a wheat or a grain feedstock, and combines that with the microprotein fermentation process, which is from a source of glucose.

We're combining the two and buy cheaper feedstock.

Replacing glucose with wheat hydrolas, we take about a 30% cost out.

That's from the zero waste process.

We take a further 20% of the cost out.

How close are you to commercialization of this?

I think we've demonstrated proof of concept at lab scale.

Our next phase is working with a technology partner next year.

We'd forecast the first microprotein using our technology scale in 2020.

OK, very good, thanks you.

More videos

Image